Compass Pathways PLC
NASDAQ:CMPS

Watchlist Manager
Compass Pathways PLC Logo
Compass Pathways PLC
NASDAQ:CMPS
Watchlist
Price: 4.89 USD -1.81% Market Closed
Market Cap: 334.4m USD
Have any thoughts about
Compass Pathways PLC?
Write Note

Compass Pathways PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Compass Pathways PLC
Total Equity Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Compass Pathways PLC
NASDAQ:CMPS
Total Equity
$225.7m
CAGR 3-Years
5%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Total Equity
$236.2m
CAGR 3-Years
324%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Total Equity
$111.5m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Total Equity
$831m
CAGR 3-Years
69%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Total Equity
ÂŁ368.8m
CAGR 3-Years
88%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Total Equity
ÂŁ548.2m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
7%

See Also

What is Compass Pathways PLC's Total Equity?
Total Equity
225.7m USD

Based on the financial report for Dec 31, 2023, Compass Pathways PLC's Total Equity amounts to 225.7m USD.

What is Compass Pathways PLC's Total Equity growth rate?
Total Equity CAGR 5Y
56%

Over the last year, the Total Equity growth was 25%. The average annual Total Equity growth rates for Compass Pathways PLC have been 5% over the past three years , 56% over the past five years .

Back to Top